Comparative study of weekly and three-weekly neoadjuvant carboplatin in triple-negative breast cancer: retrospective analysis in real-world settings

CONCLUSIONS: Weekly carboplatin exhibited comparable toxicity, a trend toward fewer interruptions, and similar pCR rates. Prospective studies are essential for validating these findings.PMID:38509430 | DOI:10.1007/s12094-024-03430-7

Source: Clinical Genitourinary Cancer - March 21, 2024 Category: Cancer & Oncology Authors: Ana Isabel Martin-Quesada Elisenda Llabres-Valent í Cristina Mar ía Montesdeoca-Godoy Carla Mart ín-Abreu Cristina Alem án-Sánchez Natalia Rodr íguez-Pérez Alicia Herrero-M árquez Josefina Cruz-Jurado Mar ía Hernández-Sosa Melody Marrero-Garc í Source Type: research